Journal
APOPTOSIS
Volume 22, Issue 1, Pages 158-168Publisher
SPRINGER
DOI: 10.1007/s10495-016-1313-7
Keywords
Cardamonin; STAT3; Prostate cancer; SH2 domain
Categories
Funding
- National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2015R1A4A1042399]
- NUHS Basic seed Grant [T1-BSRG 2015-02]
- Ministry of Education
- John Nott Cancer Fellowship from Cancer Council, Western Australia
- Deanship of Scientific Research at King Saud University [RG-1435-081]
- National Medical Research Council of Singapore [R-713-000-177-511]
- NUHS Bench-to-Bedside-To-Product [R-184-000-243-515]
- National Research Foundation Singapore
- Singapore Ministry of Education under its Research Centres of Excellence initiative
- NCIS Yong Siew Yoon Research Grant
- Department of Science and Technology [SR/FT/LS-142/2012]
Ask authors/readers for more resources
The pleiotropic transcription factor, signal transducer and activator of transcription 3 (STAT3) is often aberrantly activated in a wide variety of cancers and plays a pivotal role in tumor initiation, promotion and progression. Targeting deregulated STAT3 activation by small molecule inhibitors is generally considered as an important therapeutic strategy. Hence, in the present study, we evaluated the potential of cardamonin (CD), a 2',4'-dihydroxy-6'-methoxychalcone, to modulate STAT3 activation in prostate cancer (PC) cells and found that this chalcone can indeed exhibit significant anticancer effects through negatively regulating STAT3 activation by diverse molecular mechanism(s). CD suppressed STAT3 phosphorylation, nuclear translocation and DNA binding ability in PC cells. Computational modeling revealed that CD can bind directly to the Src Homology 2 domain of STAT3 and also effectively inhibit its dimerization. CD was also found to significantly reduce the migratory/invasive potential of PC cells through the downregulation of various oncogenic proteins. Overall, the data indicates that the potential application of CD as a STAT3 blocker can mitigate both the growth and survival of PC cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available